However, a 2015 case report identified an MTC patient with Myosin Heavy Chain 13 (MYHC13)-RET fusion (68), suggesting that oncogenic RET rearrangements also occur in MEN2B albeit at lower frequencies. Here, RET is linked to medullary thyroid gland carcinoma.